The chemical class known as LOC100040996 Inhibitors encompasses a range of compounds specifically formulated to target and inhibit the activity of the gene product expressed by LOC100040996. This gene, identified through comprehensive genomic sequencing, has been found to play a significant role in various cellular processes. The functionality of LOC100040996 is highly dependent on the cellular context, with its role varying in response to different environmental and intracellular conditions. Inhibitors designed for this gene are characterized by their ability to selectively bind to the proteins or enzymes produced as a result of LOC100040996 expression. This targeted binding is a crucial aspect of their mechanism, as it directly impacts the biochemical pathways involving the LOC100040996 gene product. By modulating the activity of this gene product, these inhibitors aim to alter the associated cellular processes, thereby influencing specific cellular functions and mechanisms.
The development of LOC100040996 Inhibitors is an intricate and interdisciplinary task, involving extensive collaboration between molecular biology, chemistry, and structural biology. The process begins with an in-depth understanding of the structure and function of the LOC100040996 gene product. Techniques such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and computational molecular modeling are employed to gain detailed insights into the target molecule. This foundational knowledge is crucial for the rational design of inhibitors that are effective in their interaction and exhibit a high degree of specificity for their target. Typically, these inhibitors are small molecules, optimized for efficient penetration into cellular membranes and to establish a stable and potent interaction with their target. The molecular design of these inhibitors is carefully tailored to ensure robust interactions with the target molecule, often involving the formation of hydrogen bonds, hydrophobic interactions, and van der Waals forces. The efficacy of these inhibitors is assessed through various biochemical assays in vitro. These assays are critical in determining the potency, specificity, and overall interaction profile of the inhibitors, providing key insights into their behavior under controlled experimental conditions. This research is vital for advancing our understanding of the inhibitors' mechanism of action and their potential impact on cellular pathways and functions influenced by LOC100040996.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Binds to DNA and inhibits RNA polymerase, potentially decreasing gene transcription. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Inhibits RNA polymerase II, potentially reducing mRNA synthesis and gene expression. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Binds to bacterial RNA polymerase, potentially inhibiting transcription initiation. | ||||||
Streptonigrin | 3930-19-6 | sc-500892 sc-500892A | 1 mg 5 mg | $104.00 $364.00 | 1 | |
Inhibits bacterial RNA polymerase and could reduce transcription. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
A diterpene triepoxide that may inhibit transcription by affecting RNA polymerase II activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Binds to mTOR and might affect downstream gene expression. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
DNA crosslinker that could hinder transcription and replication processes. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $69.00 $266.00 | 8 | |
Inhibits inosine monophosphate dehydrogenase, potentially affecting purine synthesis and RNA transcription. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Binds to DNA and may block RNA polymerase and transcription. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Intercalates into DNA and RNA, which may inhibit DNA and RNA polymerase enzymes. | ||||||